FDA Approves new drug to treat open angle glaucoma – Zioptan – MPO Cares | MPO Eyecare

FDA Approves new drug to treat open angle glaucoma – Zioptan

On Valentine’s Day, the FDA announced that they gave the green light to approve a new drug that to treat the most common form of Glaucoma, open angle glaucoma.

In the official press release, the “U.S. Food and Drug Administration approved Zioptan (tafluprost ophthalmic solution) to help reduce elevated eye pressure,” a cause of open angle glaucoma.

Glaucoma can cause complete blindness if untreated which is why your Comprehensive Eye Exam comes with a Glaucoma test.

We’re thrilled that the FDA approves of another option for the treatment of Glaucoma.

More about the drug:
Zioptan is an eye drop that should be used once daily in the evening. In clinical studies up to 24 months in duration, patients with open-angle glaucoma or ocular hypertension treated with Zioptan in the evening showed reduced eye pressure at three and six months.

Best Regards,
MPO Eyecare